Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds…
"The initial controlled launch of RemeOs™ Trauma Screws in the U.S. yielded excellent patient results, with a notable number of surgeries and successful post-healing follow-ups. This success lays the groundwork for entering the second phase of commercialization for RemeOs™ products in the U.S. and driving strong demand within the surgeon community. This agreement evidences our commitment to the RemeOs™ Trauma Product line, its commercialization, and the strengthening of distribution…
PR Newswire
20/11/2024
UNAVETS founder appointed as Senior Advisor to Oaktree Capital Management
Junko Sheehan said: "UNAVETS started five years ago with nothing but a business plan and a value proposition for the vet sector. Making that transformation from idea into concrete execution with a terrific team of committed, passionate people is what has made this journey so special. As a Senior Advisor to Oaktree, I will still be deeply involved in the strategic direction of the company alongside my partners, Oaktree, and this will afford me some time to dedicate to other consolidation and…
PR Newswire
20/11/2024
Sanofi: Information concerning the total number of voting rights and shares -…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the...
Nasdaq GlobeNewswire
20/11/2024
DermRays Amazon Black Friday Event Offers Best Deals of the Year
The DermRays V6S has redefined at-home laser hair removal, especially for users with darker skin tones, a market where safe and effective options are limited. Leveraging 1064nm laser technology-widely recognized as the gold standard in professional aesthetics. DermRays provides an effective solution with the precision of salon-grade technology in the comfort of home. This advanced laser ensures safer, more effective hair reduction for a broad range of skin tones, setting it apart as the only…
PR Newswire
20/11/2024
Perceptive Imaging Improves Oncology Trial Outcomes through Enhanced Services
There is growing concern about the amount of variability in radiotherapy treatments among investigative sites and its potential impact on pharmaceutical efficacy and toxicity evaluations. This presents a need to centrally evaluate the conformance of radiotherapy plans to the treatment guidelines for a given protocol. There is growing concern about the amount of variability in radiotherapy treatments among investigative sites and its potential impact on pharmaceutical efficacy and toxicity…
PR Newswire
20/11/2024
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
About Acurx Pharmaceuticals, Inc. About Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to...
PR Newswire
20/11/2024
Recursion and Exscientia, two leaders in the AI drug discovery space, have…
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discoveryRecursion will host an update call today, November 20, 2024 at 7:30 a.m. ET / 5:30 a.m. MT / 12:30 p.m. GMT on LinkedIn, X and...
Nasdaq GlobeNewswire
20/11/2024
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC…
Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis varieties with specific, consistent and reproducible cannabinoid and terpene profiles. Over a two-year period, a total of 5,000 seeds will be used for a comprehensive phenohunt of the Avextra cultivar. So far, 600 seeds have been utilised in the process.Led by industry experts, including former GW Pharmaceuticals Director Alan Sutton and genetics and cultivation expert Steven Tan, the...
Nasdaq GlobeNewswire
20/11/2024
BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION…
Recently, large-scale shipments were made by SpayVac for Wildlife to support a major feral horse population management project in Europe, underscoring their commitment to expanding animal population control efforts globally. This follows the production of vaccine for an immunocontraception project in Southeast Asia this past summer. Recently, large-scale shipments were made by SpayVac for Wildlife to support a major feral horse population management project inEurope, underscoring their...
PR Newswire
20/11/2024
Casino Group: Agreement for Trinity to transfer its shares in France Retail…
Agreement for Trinity to transfer its sharesin France Retail Holdings to EPEI III Paris, 20 November 2024Casino, Guichard-Perrachon (« Casino ») announces that it has been informed on 19 November 2024 of the signing of a share purchase agreement by which Trinity Investments Designated Activity Company, whose management company is Attestor Limited («Trinity») is to transfer to EP Equity Investment III S.à r.l. (« EPEI ») 1its 7.65% shareholding in France Retail Holdings S.à.r...
Nasdaq GlobeNewswire
20/11/2024
The Lazarus Practice: Ex Goldman Sachs and Headspace Leaders Pioneer a New Era…
The practice is spearheaded by visionary founders Dr Ian Dodd, a former Goldman Sachs executive who experienced a severe burnout and depression, and Dr David Cox, ex-Chief Medical Officer at Headspace. It emerges from a critical need to overcome the widespread failures of the majority of private and public mental health services. The practice is spearheaded by visionary founders DrIan Dodd, a former Goldman Sachs executive who experienced a severe burnout and depression, and DrDavid Cox,...
PR Newswire
20/11/2024
Press Release: Sequana Medical announces Extraordinary General Meeting of…
Sequana Medical announces Extraordinary General Meeting of Shareholderson 20 December 2024Ghent, Belgium – 20 November 2024– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Extraordinary General Meeting of Shareholders on Friday, 20 December 2024.The items on the agenda of…
Nasdaq GlobeNewswire
20/11/2024
AmacaThera Announces Phase 1 Results of First-in-Human Study with AMT-143…
The recent clinical data has strengthened support for AmacaThera with lead investor of AmacaThera's recently completed Series A extension Paul Austin saying "The progress shown in the Phase 1 study demonstrates the tremendous potential of AMT-143 to transform post-operative pain management. Based on these strong results, we are increasing our investment to accelerate its continuing development." The recent clinical data has strengthened support for AmacaThera with lead investor of…
PR Newswire
20/11/2024
Custom T-shirt Printing Market: Projected to Grow at a 7.20% CAGR, Reaching USD…
The Custom T-shirt Printing Market is set to grow from USD 9.23 billion in 2023 to USD 17.27 billion by 2032, at a 7.20% CAGR. Growth is driven by rising demand for personalized apparel, advancements in printing technologies, and increased adoption for promotional and corporate purposes. The e-commerce boom and eco-friendly printing practices further fuel market expansion, with North America and Asia-Pacific leading the growth. TheCustom T-shirt Printing Marketis set to grow fromUSD 9...
PR Newswire
20/11/2024
iShare-Home Residential Smart Solar System: A Comprehensive and One-Stop Choice…
Furthermore, iShare-Home Residential Solar Energy Solution features a wide range of internal components and hardware that adhere to global industry standards. With multiple certifications for all components, customers can be confident they are receiving top-quality products. Additionally, Slenergy offers a complete line of warranties on all major products and components within our PV kits and solar energy solutions with optional extended warranties upon request. Furthermore, iShare-Home...
PR Newswire
20/11/2024
Experts Unveil 'Moments of Kalmfulness' Virtual Gallery: A Digital Retreat for…
In response, Kalms Herbal Remedies has partnered with mental health experts and renowned photographers to launch the Moments of Kalmfulness Virtual Gallery - an online collection of calming photography aimed at promoting mental well-being. In response, KalmsHerbal Remedies has partnered with mental health experts and renowned photographers to launch the Moments of Kalmfulness Virtual Gallery - an online collection of calming photography aimed at promoting mental well-being...
PR Newswire
20/11/2024
Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for…
Key Takeaways from the Celiac Disease Pipeline Report Key Takeaways from the Celiac Disease Pipeline Report Request a sample and discover the recent advances in celiac disease treatment drugs @ Celiac Disease Pipeline Report The celiac disease pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage celiac disease drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an...
PR Newswire
19/11/2024
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key…
Key Takeaways from the Systemic Lupus Erythematosus Pipeline Report Key Takeaways from the Systemic Lupus Erythematosus Pipeline Report Request a sample and discover the recent advances in systemic lupus erythematosus treatment drugs @ Systemic Lupus Erythematosus Pipeline Report The systemic lupus erythematosus pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage systemic lupus erythematosus drugs, inactive and...
PR Newswire
19/11/2024
Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
19/11/2024
Preimplantation Genetic Testing Market Set to Reach $1.2 Billion by 2031, Driven…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204253 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204253 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Preimplantation Genetic Testing Market Overview 1. Market Definition and ScopePreimplantation Genetic Testing is a screening procedure used in conjunction with in vitro fertilization (IVF) to assess embryos for genetic...
PR Newswire
19/11/2024
Global Drug Discovery Technologies Market Projected to Reach $197 Billion by…
This report provides an in-depth analysis of the drug discovery technologies market, exploring trends from 2023, with estimates for 2024 and projections through 2029. It highlights the significant potential of technologies such as high-throughput screening (HTS), bioanalytical instruments, cell-based assays, genomics, bioinformatics, and proteomics, and the emerging fields of metabolomics and nanotechnology. The market is segmented by technology and application, including areas such as oncology…
PR Newswire
19/11/2024
Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing…
Dr Campbell Bunce, CSO and Cambridge Site Head at Abzena said, "We recognize that high-quality data is the cornerstone of effective decision-making. When it comes to early-phase biopharmaceutical programs, especially ADCs, developers must have a reliable CRO partner with the deep knowledge and technical capabilities required, and who can deliver the necessary data needed to successfully reach their next target inflection point." Dr Campbell Bunce, CSO and Cambridge Site Head at Abzena…
PR Newswire
19/11/2024
SKF confirms dates for CFO transition
Previous press release, 3 September 2024: [link] Previous press release,3 September 2024 : [ link ] Aktiebolaget SKF (publ) CONTACT: For further information, please contact:PRESS: Carl Bjernstam, Head of Media Relations tel: 46 31-337 2517; mobile: 46 722-201 893; e-mail:
[email protected]
INVESTOR RELATIONS: Sophie Arnius, Head of Investor Relations tel: 46 31-337 8072; mobile: 46 705-908 072; e-mail:
[email protected]
This information was brought...
PR Newswire
19/11/2024
Orion and Alligator Bioscience amend their agreement concerning two bispecific…
ORION CORPORATIONINVESTOR NEWS19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodiesOrion Corporation and Alligator Bioscience AB have agreed on the conversion of the previously granted royalty-bearing license to Orion Corporation to two bispecific antibodies that the companies have been successfully developing in collaboration using Alligator's RUBY® bispecific format to a perpetual, fully paid,...
Nasdaq GlobeNewswire
19/11/2024
Altri Comunicati
